{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:34:59Z","timestamp":1775025299600,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/nrcardio.2015.95","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T10:19:36Z","timestamp":1434449976000},"page":"447-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Losartan versus atenolol in the Marfan aorta\u2014how to treat?"],"prefix":"10.1038","volume":"12","author":[{"given":"Romy","family":"Franken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J. M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"BFnrcardio201595_CR1","doi-asserted-by":"publisher","unstructured":"Milleron, O.  et al. Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur. Heart J. \n                    http:\/\/dx.doi.org\/10.1093\/eurheartj\/ehv151\n                    \n                  .","DOI":"10.1093\/eurheartj\/ehv151"},{"key":"BFnrcardio201595_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1517\/14656566.2012.665446","volume":"13","author":"AW Hartog","year":"2012","unstructured":"Hartog, A. W., Franken, R., Zwinderman, A. H., Groenink, M. & Mulder, B. J. Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome. Expert Opin. Pharmacother. 13, 647\u2013662 (2012).","journal-title":"Expert Opin. Pharmacother."},{"key":"BFnrcardio201595_CR3","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.ijcard.2013.03.033","volume":"168","author":"R Franken","year":"2013","unstructured":"Franken, R.  et al. Circulating transforming growth factor-\u03b2 as a prognostic biomarker in Marfan syndrome. Int. J. Cardiol. 168, 2441\u20132446 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201595_CR4","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","volume":"358","author":"SB Brooke","year":"2008","unstructured":"Brooke, S. B.  et al. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N. Engl. J. Med. 358, 2787\u20132795 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201595_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","volume":"88","author":"HH Chiu","year":"2013","unstructured":"Chiu, H. H.  et al. Losartan added to \u03b2-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study. Mayo Clin. Proc. 88, 271\u2013276 (2013).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrcardio201595_CR6","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","volume":"34","author":"M Groenink","year":"2013","unstructured":"Groenink, M.  et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: an open-label randomized clinical trial. Eur. Heart J. 34, 3491\u20133500 (2013).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201595_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","volume":"8","author":"R Franken","year":"2015","unstructured":"Franken, R.  et al. Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome. Circ. Cardiovasc. Genet. 8, 383\u2013388 (2015).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio201595_CR8","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro, R. V.  et al. Atenolol versus losartan in children and young adults with Marfan's syndrome. N. Engl. J. Med. 371, 2061\u20132071 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201595_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ahj.2015.01.011","volume":"169","author":"A Pitcher","year":"2015","unstructured":"Pitcher, A.  et al. Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: a report from the Marfan Treatment Trialists' Collaboration. Am. Heart J. 169, 605\u2013612 (2015).","journal-title":"Am. Heart J."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.95.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.95","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.95.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:57:32Z","timestamp":1684468652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFnrcardio201595"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2015.95","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]},"assertion":[{"value":"16 June 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}